BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30206313)

  • 1. Application of ex-vivo spheroid model system for the analysis of senescence and senolytic phenotypes in uterine leiomyoma.
    Xie J; Xu X; Yin P; Li Y; Guo H; Kujawa S; Chakravarti D; Bulun S; Kim JJ; Wei JJ
    Lab Invest; 2018 Dec; 98(12):1575-1587. PubMed ID: 30206313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress-induced miRNAs modulate AKT signaling and promote cellular senescence in uterine leiomyoma.
    Xu X; Kim JJ; Li Y; Xie J; Shao C; Wei JJ
    J Mol Med (Berl); 2018 Oct; 96(10):1095-1106. PubMed ID: 30097674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AKT/BCL-2 Axis Mediates Survival of Uterine Leiomyoma in a Novel 3D Spheroid Model.
    Vidimar V; Chakravarti D; Bulun SE; Yin P; Nowak R; Wei JJ; Kim JJ
    Endocrinology; 2018 Mar; 159(3):1453-1462. PubMed ID: 29381777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of AKT induces cellular senescence in uterine leiomyoma.
    Xu X; Lu Z; Qiang W; Vidimar V; Kong B; Kim JJ; Wei JJ
    Endocrinology; 2014 Apr; 155(4):1510-9. PubMed ID: 24476133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA expression profiling identifies novel biomarkers in uterine leiomyoma.
    Wang W; Zhou L; Wang J; Zhang X; Liu G
    Cell Signal; 2020 Dec; 76():109784. PubMed ID: 32976932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.
    Shahbandi A; Rao SG; Anderson AY; Frey WD; Olayiwola JO; Ungerleider NA; Jackson JG
    Cell Death Differ; 2020 Nov; 27(11):3097-3116. PubMed ID: 32457483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury.
    Lim S; Kim TJ; Kim YJ; Kim C; Ko SB; Kim BS
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
    Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
    Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity.
    González-Gualda E; Pàez-Ribes M; Lozano-Torres B; Macias D; Wilson JR; González-López C; Ou HL; Mirón-Barroso S; Zhang Z; Lérida-Viso A; Blandez JF; Bernardos A; Sancenón F; Rovira M; Fruk L; Martins CP; Serrano M; Doherty GJ; Martínez-Máñez R; Muñoz-Espín D
    Aging Cell; 2020 Apr; 19(4):e13142. PubMed ID: 32233024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphenol A Concentrates Preferentially in Human Uterine Leiomyoma and Induces Proliferation in Rat Myometrium.
    Othman ER; Al-Adly DM; Elgamal DA; Ghandour N; El-Sharkawy S
    Reprod Sci; 2016 Apr; 23(4):508-14. PubMed ID: 26445998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells.
    Pungsrinont T; Sutter MF; Ertingshausen MCCM; Lakshmana G; Kokal M; Khan AS; Baniahmad A
    Cell Biosci; 2020; 10():59. PubMed ID: 32351687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.
    Xie J; Ubango J; Ban Y; Chakravarti D; Kim JJ; Wei JJ
    Genes Chromosomes Cancer; 2018 Oct; 57(10):485-494. PubMed ID: 29790226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human uterine leiomyoma contains low levels of 1, 25 dihdroxyvitamin D3, and shows dysregulated expression of vitamin D metabolizing enzymes.
    Othman ER; Ahmed E; Sayed AA; Hussein M; Abdelaal II; Fetih AN; Abou-Taleb HA; Yousef AA
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():117-122. PubMed ID: 30172168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
    Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL
    Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of liver depression and psychological stress on human uterine leiomyoma cells by an AR-cAMP-PKA signal transduction pathway.
    Xia T; Li S; Ma R; Guan S; Li J; Li H; Zhang H; Lin Q; Zhao Z; Wang B
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):291-301. PubMed ID: 28600036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxyelephantopin, a novel naturally occurring phytochemical impairs growth, induces G2/M arrest, ROS-mediated apoptosis and modulates lncRNA expression against uterine leiomyoma.
    Pandey V; Tripathi A; Rani A; Dubey PK
    Biomed Pharmacother; 2020 Nov; 131():110751. PubMed ID: 33152917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice.
    Tarantini S; Balasubramanian P; Delfavero J; Csipo T; Yabluchanskiy A; Kiss T; Nyúl-Tóth Á; Mukli P; Toth P; Ahire C; Ungvari A; Benyo Z; Csiszar A; Ungvari Z
    Geroscience; 2021 Oct; 43(5):2427-2440. PubMed ID: 34427858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of miR-197 inhibits cell proliferation by directly targeting IGFBP5 in human uterine leiomyoma cells.
    Ling J; Jiang L; Zhang C; Dai J; Wu Q; Tan J
    In Vitro Cell Dev Biol Anim; 2015 Sep; 51(8):835-42. PubMed ID: 25990270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.
    Chang J; Wang Y; Shao L; Laberge RM; Demaria M; Campisi J; Janakiraman K; Sharpless NE; Ding S; Feng W; Luo Y; Wang X; Aykin-Burns N; Krager K; Ponnappan U; Hauer-Jensen M; Meng A; Zhou D
    Nat Med; 2016 Jan; 22(1):78-83. PubMed ID: 26657143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SYK inhibitor, R406 as a novel senolytic agent.
    Cho HJ; Yang EJ; Park JT; Kim JR; Kim EC; Jung KJ; Park SC; Lee YS
    Aging (Albany NY); 2020 May; 12(9):8221-8240. PubMed ID: 32379705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.